Results 121 to 130 of about 359,688 (261)
Immunological Demonstration of a Substance in Rat Blood Associated with Tissue Growth
D. A. DARCY
openalex +1 more source
Single‐cell transcriptomics of prostate cancer patient‐derived xenografts reveals distinct features of neuroendocrine (NE) subtypes. Tumours with focal NE differentiation (NED) share transcriptional programmes with adenocarcinoma, differing from large and small cell neuroendocrine prostate cancer (NEPC). Our work defines the molecular landscape of NEPC,
Rosalia Quezada Urban+12 more
wiley +1 more source
2-Chloroethyl Trimethylammonium Chloride and Related Compounds as Plant Growth Substances. V. Growth, Flowering, and Fruiting Responses as Related to Those Induced by Auxin and Gibberellin [PDF]
S. H. Wittwer, N. E. Tolbert
openalex +1 more source
Decrypting cancer's spatial code: from single cells to tissue niches
Spatial transcriptomics maps gene activity across tissues, offering powerful insights into how cancer cells are organised, switch states and interact with their surroundings. This review outlines emerging computational, artificial intelligence (AI) and geospatial approaches to define cell states, uncover tumour niches and integrate spatial data with ...
Cenk Celik+4 more
wiley +1 more source
Application of Antifreeze Substances in Food Cryopreservation. [PDF]
Wu M+5 more
europepmc +1 more source
Growth-Promoting Substance and Illumination [PDF]
openaire +3 more sources
This study explores salivary RNA for breast cancer (BC) diagnosis, prognosis, and follow‐up. High‐throughput RNA sequencing identified distinct salivary RNA signatures, including novel transcripts, that differentiate BC from healthy controls, characterize histological and molecular subtypes, and indicate lymph node involvement.
Nicholas Rajan+9 more
wiley +1 more source
The Role of Phosphorus Sources and Phytase in Growth Performance and Feed Digestibility in Broilers. [PDF]
Coudert E+6 more
europepmc +1 more source
Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology
Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts+8 more
wiley +1 more source